Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test

  • Hollingshead C
  • Ciricillo J
  • Kammeyer J
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fecal microbiota transplantation (FMT) has gained popularity as an effective therapeutic option for Clostridioides difficile infection (CDI). Since its FDA recognition as a treatment modality for recurrent CDI in 2013, screening protocols for FMT donor stool have been in flux. However, extensive health questionnaires, in combination with serological and stool assays, have become mainstays in the donor screening process, although ethical implications are yet to be thoroughly considered. Herein, we present the case of a family member found to have a false-positive HIV test during the donor screening process and discuss potential ethical ramifications associated with FMT stool donation.

Cite

CITATION STYLE

APA

Hollingshead, C., Ciricillo, J., & Kammeyer, J. (2021). Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test. Case Reports in Infectious Diseases, 2021, 1–3. https://doi.org/10.1155/2021/6696542

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free